Outcome of Board Meeting held today i.e., August 02, 2025 for the quarter June 30, 2025
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services reported consolidated revenue from operations of Rs. 1,542.6 crore for Q1 FY26 (June 2025), up about 3.6% from Rs. 1,488.8 crore in Q1 FY25. Net profit after tax surged to Rs. 42.3 crore from Rs. 14.3 crore in the same quarter last year, a near-tripling driven by lower purchase costs and higher other income. Basic EPS rose to Rs. 3.54 from Rs. 1.20 (restated). On the standalone basis, revenue grew modestly to Rs. 183.9 crore while PAT rose to Rs. 13.5 crore from Rs. 9.3 crore. The Board also appointed a new Secretarial Auditor for five years (FY26–FY30) and a Cost Auditor for FY26, allotted 79,157 shares under ESOP 2021, and scheduled the 19th AGM for September 15, 2025.
Strong profit growth, nearly tripling year-on-year, signals improving margins and operational efficiency, likely positive for the stock despite modest top-line growth. Shareholders should note the small ESOP dilution and the pending shareholder approval for the Secretarial Auditor appointment at the AGM.